These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 20951660)
1. Human embryonic stem cells and derived contractile embryoid bodies are susceptible to Coxsakievirus B infection and respond to interferon Iβ treatment. Scassa ME; Jaquenod de Giusti C; Questa M; Pretre G; Richardson GA; Bluguermann C; Romorini L; Ferrer MF; Sevlever GE; Miriuka SG; Gómez RM Stem Cell Res; 2011 Jan; 6(1):13-22. PubMed ID: 20951660 [TBL] [Abstract][Full Text] [Related]
2. Activation of apoptotic signalling events in human embryonic stem cells upon Coxsackievirus B3 infection. Romorini L; Scassa ME; Videla Richardson G; Blüguermann C; Jaquenod de Giusti C; Questa M; Fernandez Espinosa DD; Gómez RM; Sevlever GE; Miriuka SG Apoptosis; 2012 Feb; 17(2):132-42. PubMed ID: 22012335 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor. Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067 [TBL] [Abstract][Full Text] [Related]
4. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication. Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333 [TBL] [Abstract][Full Text] [Related]
5. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor. Liu JY; Wang SM; Chen IC; Yu CK; Liu CC Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection. Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860 [TBL] [Abstract][Full Text] [Related]
7. Combination treatment with ribavirin and interferon for coxsackievirus B3 replication. Okada I; Matsumori A; Matoba Y; Tominaga M; Yamada T; Kawai C J Lab Clin Med; 1992 Oct; 120(4):569-73. PubMed ID: 1328433 [TBL] [Abstract][Full Text] [Related]
8. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity. Zhang K; Yu H; Xie W; Xu Z; Zhou S; Huang C; Sheng H; He X; Xiong J; Qian G J Biotechnol; 2013 Apr; 164(4):461-8. PubMed ID: 23376619 [TBL] [Abstract][Full Text] [Related]
9. The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Asher DR; Cerny AM; Finberg RW Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12897-902. PubMed ID: 16123123 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts. Heim A; Pfetzing U; Müller G; Grumbach IM Antiviral Res; 1998 Jan; 37(1):47-56. PubMed ID: 9497072 [TBL] [Abstract][Full Text] [Related]
11. Eclipse of coxsackievirus infectivity: the restrictive event for a non-fusing myogenic cell line. Schultz M; Crowell RL J Gen Virol; 1983 Aug; 64 (Pt 8)():1725-34. PubMed ID: 6308134 [TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells. Bertin A; Sane F; Gmyr V; Lobert D; Dechaumes A; Kerr-Conte J; Pattou F; Hober D Viruses; 2019 Jul; 11(7):. PubMed ID: 31269669 [TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. Heim A; Canu A; Kirschner P; Simon T; Mall G; Hofschneider PH; Kandolf R J Infect Dis; 1992 Nov; 166(5):958-65. PubMed ID: 1328409 [TBL] [Abstract][Full Text] [Related]
14. Persistent infection of a carcinoma thyroid cell line with coxsackievirus B. Desailloud R; Sané F; Caloone D; Hober D Thyroid; 2009 Apr; 19(4):369-74. PubMed ID: 19292692 [TBL] [Abstract][Full Text] [Related]
15. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4. Goffard A; Alidjinou EK; Sané F; Choteau L; Bouquillon C; Caloone D; Lobert PE; Hober D Microbes Infect; 2013 Jan; 15(1):18-27. PubMed ID: 23108316 [TBL] [Abstract][Full Text] [Related]
16. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. Zanone MM; Favaro E; Ferioli E; Huang GC; Klein NJ; Perin PC; Peakman M; Conaldi PG; Camussi G FASEB J; 2007 Oct; 21(12):3308-17. PubMed ID: 17494992 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes. Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481 [TBL] [Abstract][Full Text] [Related]
18. Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells. Alidjinou EK; Sané F; Engelmann I; Hober D J Mol Biol; 2013 Dec; 425(24):5020-31. PubMed ID: 24120940 [TBL] [Abstract][Full Text] [Related]
19. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes. Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573 [TBL] [Abstract][Full Text] [Related]
20. Experimental SSM-CVB3 infection in macaques. Han T; He W; Song D; Zhao K; Wu C; Gao F; Lu H; Gai X; Wang X; Li F; Ji C; Lin X Exp Mol Pathol; 2012 Feb; 92(1):131-9. PubMed ID: 22079478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]